• In late June 2026, Valaris Limited (NYSE: VAL) was added to several Russell growth benchmarks, including the Russell 2000, 2500, 3000, 3000E and Small Cap Composite Growth Indexes, while being removed from the Russell 2000 Defensive and Russell 2000 Value-Defensive Indexes.
• This reclassification signals a meaningful shift in how index providers and, by extension, many institutional investors categorize Valaris, potentially altering who holds the stock and how it is used in portfolios.
• We’ll now examine how Valaris’ move into multiple Russell growth benchmarks could influence the company’s existing investment narrative and risk profile.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Valaris Investment Narrative Recap

To own Valaris today, you need to believe offshore drilling will remain central to global energy and that the company’s US$4.7 billion backlog can translate into steadier earnings despite industry volatility. The recent shift into Russell growth indexes may influence which funds hold the stock, but it does not materially change the near term focus on execution risk, contract timing, and the ongoing regulatory review of the proposed Transocean acquisition as the key drivers to watch.

The Russell reclassification lands just months after Transocean agreed to acquire Valaris in an all stock deal valuing Valaris at US$5.7 billion, with closing targeted for the second half of 2026. That pending combination, alongside the recent Petrobras contract extension that added about US$447 million of backlog, remains far more central to the investment story than index membership, especially for investors focused on contract visibility and regulatory outcomes.

Yet against this stronger growth label, investors should still be aware of how any delay or change in the Transocean deal could...

Valaris' narrative projects $2.5 billion revenue and $261.5 million earnings by 2029.

Uncover how Valaris' forecasts yield a $70.68 fair value, a 5% downside to its current price.

Exploring Other Perspectives

While the index move tilts Valaris toward a growth label, the most pessimistic analysts still expected earnings to fall to about US$569 million by 2029 and margins to compress, reminding you that views can differ widely and both the deal risk and these new index changes could reshape those expectations.

Explore 4 other fair value estimates on Valaris - why the stock might be worth 40% less than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Valaris research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Valaris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Valaris' overall financial health at a glance.

Ready For A Different Approach?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Find 42 companies with promising cash flow potential yet trading below their fair value.
• Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.